Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Neuroendocrine Tumors, Somatostatin Analogues

Martyn Caplin

MD

🏢Royal Free Hospital / University College London🌐UK

Professor of Gastroenterology

52
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Martyn Caplin at Royal Free Hospital has made contributions to neuroendocrine tumor (NET) management, including leading the CLARINET trial that established lanreotide autogel as anti-proliferative therapy for non-functional gastroenteropancreatic NETs. His work on somatostatin receptor-targeted therapy and imaging in NETs contributed to the evidence base for somatostatin analogue use and the theranostics framework leveraging somatostatin receptor expression.

Share:

🧪Research Fields 研究领域

neuroendocrine tumors
somatostatin receptor imaging
octreotide LAR
CLARINET trial
lanreotide NET

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Martyn Caplin 的研究动态

Follow Martyn Caplin's research updates

留下邮箱,当我们发布与 Martyn Caplin(Royal Free Hospital / University College London)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment